Evidence map›Paper›PMID 32883358›Full record

ArticleJournal of neuroinflammation2020

Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 2: Results from 108 lumbar punctures in 80 pediatric patients.

Sven Jarius, Christian Lechner, Eva M Wendel, Matthias Baumann, Markus Breu, Mareike Schimmel, Michael Karenfort, Adela Della Marina, Andreas Merkenschlager, Charlotte Thiels and 29 more

Abstract read
In one paragraph

Article in Journal of neuroinflammation, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Clinical features of recurrent MOG antibody-associated cortical encephalitis in adults.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2025
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Review
  20. Attack phenotypes and disease course in pediatric MOGAD.Annals of clinical and translational neurology · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

39 authors.

Sven JariusMolecular Neuroimmunology Group, Department of Neurology, University of Heidelberg, Heidelberg, Germany. sven.jarius@med.uni-heidelberg.de.
Christian LechnerDivision of Pediatric Neurology, Department of Pediatrics I, Medical University of Innsbruck, Innsbruck, Austria.
Eva M WendelDepartment of Pediatrics, Olgahospital, Klinikum Stuttgart, Stuttgart, Germany.
Matthias BaumannDivision of Pediatric Neurology, Department of Pediatrics I, Medical University of Innsbruck, Innsbruck, Austria.
Markus BreuDepartment of Pediatric and Adolescent Medicine, Medical University of Vienna, Vienna, Austria.
Mareike SchimmelDivision of Pediatric Neurology, Children's Hospital, Medical University of Augsburg, Augsburg, Germany.
Michael KarenfortDepartment of General Pediatrics, Neonatology and Pediatric Cardiology, University Children's Hospital, Heinrich-Heine-University, Düsseldorf, Germany.
Adela Della MarinaDepartment of Neuropediatrics, Developmental Neurology and Social Pediatrics, Children's Hospital, University of Duisburg-Essen, Duisburg, Germany.
Andreas MerkenschlagerDivision of Pediatric Neurology, University Hospital for Children and Adolescents, Leipzig, Germany.
Charlotte ThielsDepartment of Neuropediatrics, University Children's Hospital, Ruhr-University Bochum, Bochum, Germany.
Astrid BlaschekDepartment of Pediatric Neurology and Developmental Medicine, Dr. von Hauner Children's Hospital, University of Munich, Munich, Germany.
Michela SalandinDepartment of Pediatrics, Bozen Hospital, Bozen, Italy.
Steffen LeizDepartment of Pediatrics, Division of Pediatric Neurology, Klinikum Dritter Orden, Munich, Germany.
Frank LeypoldtNeuroimmunology, Institute of Clinical Chemistry and Department of Neurology, Christian-Albrechts-University Kiel and Medical University Hospital Schleswig-Holstein, Kiel, Germany.
Alexander PschibulDepartment of Neuropediatrics and Muscle Disorders, University Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Annette HackenbergDivision of Pediatric Neurology, University Children's Hospital Zurich, Zurich, Switzerland.
Andreas HahnDepartment of Pediatric Neurology, University Children's Hospital Giessen, Giessen, Germany.
Steffen SyrbeDivision of Child Neurology and Inherited Metabolic Diseases, Department of General Pediatrics, Center for Child and Adolescent Medicine, Heidelberg University Hospital, Heidelberg, Germany.
Jurgis StrautmanisDepartment of Neurology, Children's Clinical University Hospital, Riga, Latvia.
Martin HäuslerDepartment of Pediatrics, Division of Neuropediatrics and Social Pediatrics, Medical University RWTH Aachen, Aachen, Germany.
Peter KriegDepartment of Pediatrics, Städtisches Klinikum Karlsruhe, Karlsruhe, Germany.
Astrid EisenkölblDepartment of Pediatrics, Women's and Children's Hospital, Linz, Austria.
Johannes StoffelsDepartment of Pediatric Neurology, Children's Hospital Neuburg, Neuburg, Germany.
Matthias EckenweilerDepartment of Neuropediatrics and Muscle Disorders, University Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Ilya AyzenbergDepartment of Neurology, St Josef Hospital, Ruhr-University Bochum, Bochum, Germany.
Jürgen HaasMolecular Neuroimmunology Group, Department of Neurology, University of Heidelberg, Heidelberg, Germany.
Romana HöftbergerInstitute of Neurology, Medical University of Vienna, Vienna, Austria.
Ingo KleiterDepartment of Neurology, St Josef Hospital, Ruhr-University Bochum, Bochum, Germany.
Mirjam Korporal-KuhnkeMolecular Neuroimmunology Group, Department of Neurology, University of Heidelberg, Heidelberg, Germany.
Marius RingelsteinDepartment of Neurology, Medical Faculty, Heinrich Heine University Dusseldorf, Düsseldorf, Germany.
Klemens RuprechtDepartment of Neurology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Nadja SiebertNeuroCure Clinical Research Center, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Kathrin SchandaClinical Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria.
Orhan AktasDepartment of Pediatric Neurology, Children's Hospital Neuburg, Neuburg, Germany.
Friedemann PaulNeuroCure Clinical Research Center, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Markus ReindlClinical Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria.
Brigitte WildemannMolecular Neuroimmunology Group, Department of Neurology, University of Heidelberg, Heidelberg, Germany.
Kevin RostásyDepartment of Pediatric Neurology, Children's Hospital Datteln, University Witten/Herdecke, Datteln, Germany. k.rostasy@kinderklinik-datteln.de.
in cooperation with the BIOMARKER study group and the Neuromyelitis optica Study Group (NEMOS)

Funding

Deutsche Forschungsgemeinschaft (DFG Exc 257) N/ADietmar Hopp Stiftung N/AERA-net LE3064/2-1German Federal Ministry of Education and Research (BMBF) 01GM1908AGerman Federal Ministry of Education and Research (BMBF/KKNMS, Competence Network Multiple Sclerosis) N/AJubilaeumsfonds of the Austrian National Bank 14158 and 15918Merck Serono Germany N/A
6 · The paper itself

Abstract

backgroundNew-generation, cell-based assays have demonstrated a robust association of serum autoantibodies to full-length human myelin oligodendrocyte glycoprotein (MOG-IgG) with (mostly recurrent) optic neuritis, myelitis, and brainstem encephalitis, as well as with neuromyelitis optica (NMO)-like or acute-disseminated encephalomyelitis (ADEM)-like presentations. However, only limited data are yet available on cerebrospinal fluid (CSF) findings in MOG-IgG-associated encephalomyelitis (MOG-EM; also termed MOG antibody-associated disease, MOGAD).

objectiveTo describe systematically the CSF profile in children with MOG-EM. MATERIAL AND

methodsCytological and biochemical findings (including white cell counts [WCC] and differentiation; frequency and patterns of oligoclonal bands; IgG/IgM/IgA and albumin concentrations and CSF/serum ratios; intrathecal IgG/IgM/IgA fractions; locally produced IgG/IgM/IgA concentrations; immunoglobulin class patterns; IgG/IgA/IgM reibergrams; Link index; measles/rubella/zoster [MRZ] reaction; other anti-viral and anti-bacterial antibody indices; CSF total protein; CSF L-lactate) from 108 lumbar punctures in 80 pediatric patients of mainly Caucasian descent with MOG-EM were analyzed retrospectively.

resultsMost strikingly, CSF-restricted oligoclonal IgG bands, a hallmark of multiple sclerosis (MS), were absent in 89% of samples (N = 96), and the MRZ reaction, the most specific laboratory marker of MS known so far, in 100% (N = 29). If present at all, intrathecal IgG synthesis was low, often transient and mostly restricted to acute attacks. Intrathecal IgM synthesis was present in 21% and exclusively detectable during acute attacks. CSF WCC were elevated in 54% of samples (median 40 cells/μl; range 6-256; mostly lymphocytes and monocytes; > 100/μl in 11%). Neutrophils were present in 71% of samples; eosinophils, activated lymphocytes, and plasma cells were seen only rarely (all < 7%). Blood-CSF barrier dysfunction (as indicated by an elevated albumin CSF/serum ratio) was present in 46% of all samples (N = 79) and at least once in 48% of all patients (N = 67) tested. CSF alterations were significantly more frequent and/or more pronounced in patients with acute spinal cord or brain disease than in patients with acute ON and varied strongly depending on attack severity. CSF L-lactate levels correlated significantly with the spinal cord lesions load (measured in vertebral segments) in patients with acute myelitis (p = 0.0099). An analysis of pooled data from the pediatric and the adult cohort showed a significant relationship of QAlb (p < 0.0005), CST TP (p < 0.0001), and CSF L-lactate (p < 0.0003) during acute attacks with age.

conclusionMOG-IgG-associated EM in children is characterized by CSF features that are distinct from those in MS. With regard to most parameters, no marked differences between the pediatric cohort and the adult cohort analyzed in Part 1 were noted. Our findings are important for the differential diagnosis of pediatric MS and MOG-EM and add to the understanding of the immunopathogenesis of this newly described autoimmune disease.

Indexed as

AdolescentAutoantibodiesChildChild, PreschoolEncephalomyelitisFemaleHumansImmunoglobulinsInfantMaleMyelin-Oligodendrocyte GlycoproteinOligoclonal BandsRetrospective StudiesSpinal PunctureAutoantibodiesImmunoglobulinsMyelin-Oligodendrocyte GlycoproteinOligoclonal BandsAcute disseminated encephalomyelitis (ADEM)AntibodiesBrainstem encephalitisCerebrospinal fluidChildrenEncephalomyelitisLumbar punctureMOG antibody-associated disease (MOGAD)Multiple sclerosis (MS)Myelin oligodendrocyte glycoprotein (MOG)Neuromyelitis optica (Devic syndrome)NMO spectrum disordersOligoclonal bandsOptic neuritisTransverse myelitis

Identifiers

PMID32883358
PMCPMC7470445

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.